Last reviewed · How we verify
NCT05213039: cp
Validity and Reliability of the the Timed 360° Turn Test
trial testing assessments in Cerebral Palsy in 91 participants. Completed in 15 March 2024.
15 March 2024
Quick facts
| Lead sponsor | Kahramanmaras Sutcu Imam University |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 91 |
| Start date | 15 July 2022 |
| Primary completion | 15 March 2024 |
| Estimated completion | 15 March 2024 |
| Sites | 1 location across Turkey (Türkiye) |
Drugs / interventions tested
- assessments
Conditions studied
- Cerebral Palsy — all drugs for Cerebral Palsy →
- Gait, Spastic — all drugs for Gait, Spastic →
- Gait Disorders in Children — all drugs for Gait Disorders in Children →
- Diplegic Cerebral Palsy — all drugs for Diplegic Cerebral Palsy →
Sponsor
Kahramanmaras Sutcu Imam University
Who can join
Adults 7 to 18, any sex, with Cerebral Palsy or Gait, Spastic. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Cerebral Palsy (CP) is a non-progressive neurodevelopmental disorder that starts in the early stages of life, causes activity limitation, and consists of movement and posture deficiencies. Children with CP usually have difficulties in mobility, transfer and social participation due to many motor and sensory disorders such as muscle weakness, decreased postural control, balance, spasticity. Many children with CP have difficulty in balancing independently, walking, walking on hills/uneven ground, and performing daily physical functions.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05213039
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of assessments
Trials testing the same drug.
- NCT05573711 — Restless Legs Syndrome in People With Neuromyelitis Optica Spectrum Disorder · unknown
- NCT04653363 — Evaluation of the Applicability and Reliability of the Three Meter Backwalk Test in Children With Cerebral Palsy (CP) · completed
- NCT02730039 — Meaning-Centered Psychotherapy Training for Cancer Care Providers · active not recruiting
Other recruiting trials for Cerebral Palsy
Currently open trials in the same condition.
- NCT07524972 — Antenatal Magnesium Sulphate in High-Risk Preterm Patients · Phase 3 · recruiting
- NCT07432789 — Metrological Properties of a Digital Motion Analysis Research Application for Assessing the Motor Abilities and Performa · NA · recruiting
- NCT07466914 — Constipation in Children With Cerebral Palsy · active not recruiting
- NCT05901259 — The EXOPULSE Study - a Database for Routine Follow-up of Clinical Outcomes · recruiting
- NCT07342348 — Using Power Mobility Training to Promote Arm & Hand Function in Children With Cerebral Palsy · NA · recruiting
Other Kahramanmaras Sutcu Imam University trials
Trials by the same sponsor.
- NCT07511322 — Enteral Nutrition Education Provided Using the Pecha Kucha Method · enrolling by invitation
- NCT07515287 — Restoration of Sensorimotor Function in Middle-Aged Women With Chronic Lumbar Disc Herniation: The Effect of Pilates on · NA · enrolling by invitation
- NCT07451691 — The Effect of the World Health Organisation-Based Intrapartum Care Model on Labour Pain, Comfort, Satisfaction and Postp · NA · not yet recruiting
- NCT07471412 — Sexually Transmitted Infections in Migrant Women · NA · not yet recruiting
- NCT07332065 — The Effects of Mandala Coloring on Women During Menopause · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05213039 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Kahramanmaras Sutcu Imam University
- Last refreshed: 20 March 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05213039.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing